MK
EW icon

MASTERINVEST Kapitalanlage’s Edwards Lifesciences EW Stock Holding History

MASTERINVEST Kapitalanlage’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.51M Buy
38,750
+18,119
+88% +$1.52M 0.3% 81
2026
Q1 		$1.65M Sell
20,631
-1,643
-7% -$135K 0.17% 133
2025
Q4 		$1.92M Hold
22,274
– – 0.18% 128
2025
Q3 		$1.73M Hold
22,274
– – 0.17% 135
2025
Q2 		$1.74M Buy
+22,274
New +$1.66M 0.18% 131

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

MASTERINVEST Kapitalanlage's EW Position: Q2 2026 in Review

MASTERINVEST Kapitalanlage increased its Edwards Lifesciences (EW) stake by 88% in Q2 2026, buying an estimated $1.52M and bringing the position to 38,750 shares worth $3.51M. The position accounts for 0.3% of the portfolio, ranked #81.

MASTERINVEST Kapitalanlage first reported a position in EW in Q2 2025 and has held it in 5 quarters since. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • MASTERINVEST Kapitalanlage held 38,750 shares of Edwards Lifesciences worth $3.51M as of Q2 2026.
  • MASTERINVEST Kapitalanlage bought 18,119 Edwards Lifesciences shares in Q2 2026, an estimated $1.52M.
  • Edwards Lifesciences made up 0.3% of MASTERINVEST Kapitalanlage's portfolio in Q2 2026, its #81 holding.
  • MASTERINVEST Kapitalanlage first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 5 quarters since.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on MASTERINVEST Kapitalanlage's 13F filing for Q2 2026, filed 17 Aug 2026.